Status:
RECRUITING
Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Von Willebrand Diseases
Major Constitutional Thrombopathy
Eligibility:
All Genders
18+ years
Brief Summary
Currently, the exploration of primary hemostasis (a physiological phenomenon used to stop bleeding) is imperfect because it is based on targeted tests for platelets or von Willebrand factor, without t...
Eligibility Criteria
Inclusion
- person who has given oral consent
- adult
- blood donor at EFS Bourgogne Franche-Comté
- or patient with von Willebrand disease or major constitutional thrombopathy followed by the Resource and Competence Centre (CRC) - Constitutional Hemorrhagic Diseases of Dijon or Besançon
- or patient on antiplatelet drugs consulting for thrombosis at the Dijon Bourgogne or Besançon Hospital
Exclusion
- a person who is not affiliated to or not a beneficiary of national health insurance
- person subject to court-ordered protection (curatorship, guardianship)
- pregnant, parturient or breastfeeding woman
- a person who is unable to consent
- person on anti-inflammatory treatment and serotonin reuptake inhibitor antidepressants (platelet function disorders)
Key Trial Info
Start Date :
May 6 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03773159
Start Date
May 6 2019
End Date
May 1 2026
Last Update
May 1 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Besançon
Besançon, France
2
CHU Dijon Bourgogne
Dijon, France